European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

onepharm Research & Development GmbH, Vienna, Austria

Watch
onepharm Research & Development GmbH

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Premium Service
Unlock Dossier
What is a Dossier?
A dossier provides comprehensive company details as a PDF, together with all underlying original publications and original data in one place.
The download feature is exclusively available for our paid plan. Upgrade your account to access:
Quick Dossier
Entire company details as a PDF
Power Dossier
Entire company details along with all original publications / original data bundled in a ZIP file
Upgrade to unlock all features

Premium plans starting from €/month

Learn more
Learn more
View plans

Name

onepharm Research & Development GmbH

Identification

Fb
Firmenbuch 265338d
EUID
ATBRA.265338-000

Address

Löwengasse 45, 1030 Wien, Austria

Corporate purpose

Operation of a pharmaceutical company

Financial performance

Earnings

For this company, Earnings numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

Revenue

For this company, Revenue numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Marketing & Tech

Network

Loading network

Legal Structure

Current legal representatives Legal form information · Proxy policies Premium
Premium
1Managing Director
1Authorized signatory (ppa)
Upgrade to unlock all features

Premium plans starting from €/month

Learn more View plans
Learn more View plans
Ownership relations Premium + Ownership & Flags add-on
Premium + Ownership & Flags add-on
Shareholders and Investors
One known shareholder
Upgrade to unlock all features

Premium plans starting from €/month

Learn more View plans
Learn more View plans

Financials

Key Performance Indicators Financial · Mktg & Tech Premium
Premium
Base/share capital
Total assets
Earnings
Earnings CAGR
Revenue
Revenue CAGR
Return on sales
Equity
Equity ratio
Return on equity
Cash on hand
Receivables
Liabilities
Patents
Upgrade to unlock all features

Premium plans starting from €/month

Learn more View plans
Learn more View plans
Financial Statements Interactive sheets with CSV/Excel download Premium
Premium
Balance
from 2016 to 2025
Upgrade to unlock all features

Premium plans starting from €/month

Learn more View plans
Learn more View plans

Publications

30 Sept 2026
Annual report for the year ending 31/12/2025 · Balance sheet for 31/12/2025
16 Sept 2025
Annual report for the year ending 31/12/2024 · Balance sheet for 31/12/2024
26 Sept 2024
Annual report for the year ending 31/12/2023 · Balance sheet for 31/12/2023
23 Sept 2023
Annual report for the year ending 31/12/2022 · Balance sheet for 31/12/2022
15 Jul 2023
Authorized signatory (ppa): Udo Elsner
6 Jul 2023
Shareholder: onepharm Beteiligungs GmbH · No longer Shareholder: Avir Greenhills Beteiligungsverwaltungs GmbH, MITTEREGGER Steuerberatungs-GmbH · Capital: €150,000
15 Jun 2023
Shareholder: onepharm Beteiligungs GmbH · Capital: €150,000
21 Dec 2022
Address
23 Sept 2022
Annual report for the year ending 31/12/2021 · Balance sheet for 31/12/2021
28 Dec 2021
Annual report for the year ending 31/12/2020 · Balance sheet for 31/12/2020
18 Dec 2021
Shareholder: onepharm Beteiligungs GmbH · No longer Shareholder (3 companies) · Capital: €35,000
24 Sept 2020
Annual report for the year ending 31/12/2019 · Balance sheet for 31/12/2019
24 Apr 2020
Shareholder (6 companies) · Capital: €35,000
5 Sept 2019
Annual report for the year ending 31/12/2018 · Balance sheet for 31/12/2018
21 Aug 2019
Resolution of the Annual General Meeting of 28.05.2019 Capital reduction by EUR 375,000 to EUR 35,000 intended
20 Aug 2019
No longer Shareholder (1) · Shareholder: Löwengasse 45 Liegenschaftsverwertung GmbH, onepharm Beteiligungs GmbH · No longer Shareholder: I4G Investment GmbH · Capital: €410,000
21 Sept 2018
Annual report for the year ending 31/12/2017 · Balance sheet for 31/12/2017
11 Oct 2017
No longer Shareholder (4) · Shareholder: KHtec GmbH, Löwengasse 45 Liegenschaftsverwertung GmbH, M. Hatschek Immobilienverwaltungs GmbH · Capital: €410,000
29 Sept 2017
Annual report for the year ending 31/12/2016 (only announcement)
4 Oct 2016
Annual report for the year ending 31/12/2015 (only announcement)
1 Oct 2015
Annual report for the year ending 31/12/2014 (only announcement)
27 Sept 2014
Annual report for the year ending 31/12/2013 (only announcement)
3 Oct 2013
Annual report for the year ending 31/12/2012 (only announcement)
10 Oct 2012
Annual report for the year ending 31/12/2011 (only announcement)
24 Sept 2011
Annual report for the year ending 31/12/2010 (only announcement)
17 Sept 2011
No longer Managing Director (1)
9 Aug 2011
Patent: Novel Triterpene Derivatives
9 Aug 2011
Patent: Glycyrrhetinic Acid Amine Analogues for USE in the Treatment of Inflammation, Infectious Diseases, Cancer, Autoimmune Diseases, Skin Diseases, Bone Diseases and Metabolic Diseases
1 Apr 2011
Shareholder (5) · Shareholder: I4G Investment GmbH, MITTEREGGER Steuerberatungs-GmbH, onepharm Beteiligungs GmbH · Capital: €410,000
29 Mar 2011
Shareholder (5) · Shareholder: I4G Investment GmbH, onepharm Beteiligungs GmbH · Capital: €410,000
8 Oct 2010
Annual report for the year ending 31/12/2009 (only announcement)
15 Jun 2010
Annual report for the year ending 31/12/2008 (only announcement)
1 Jun 2010
Patent: Antiviral Triterpene Derivatives
10 Mar 2010
Patent: N-Hydroxy C29-Amide Derivatives of Oleandrane
9 Oct 2009
Shareholder (5) · Shareholder: I4G Investment GmbH · Capital: €209,970
19 Jun 2009
Annual report for the year ending 31/12/2007 (only announcement)
2 Jun 2009
Patent: Antiviral Triterpene Derivatives
13 Mar 2009
Patent: Novel Triterpene Derivatives
10 Dec 2008
Patent: Prevention and Treatment of Inflammation-Induced and/or Immune-Mediated Bone Loss
27 Nov 2007
Annual report for the year ending 31/12/2006 (only announcement)
29 Aug 2007
Address
6 Jul 2007
Shareholder (4) · Shareholder: I4G Investment GmbH · Capital: €197,840
24 Aug 2006
Shareholder (4) · Capital: €167,360
9 Aug 2006
Patent: The Application of Glycyrrhizic Acid and ITS Breakdown Product Glycyrrhetinic Acid for the Manufacture of a Medicament for the Treatment of Inflammatory Bowel Disease
30 Jun 2006
Annual report for the year ending 31/12/2005 (only announcement)
27 Jan 2006
Managing Director (1) · Shareholder: Avir Greenhills Beteiligungsverwaltungs GmbH, onepharm Beteiligungs GmbH · Capital: €150,000
29 Jul 2005
Reg­is­tra­tion: 29/07/2005 · MD: B. K. · SH: Avir Greenhills Beteiligungsverwaltungs GmbH, onepharm Beteiligungs GmbH · Address · Deadline for annual balance: 31.12. · Capital: €35,000 …
There are no publications matching your search.

Mentions

via WZ in Wzfma
Change of shareholdings: Savira pharmaceuticals GmbH · Shareholding: Savira pharmaceuticals GmbH
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Printing is only available to North Data premium service subscribers.